While genetic testing is not yet standard practice, researchers believe personalized obesity treatment may become more common in the future
III faza to due randomizowane badania kontrolowane porwnujce nowy lek ze standardowym leczeniem albo placebo, dajc mocne dowody skutecznoci i bezpieczestwa
NICE guidance recommends GLP-1 receptor agonists for type 2 diabetes when triple therapy is insufficient and specific BMI criteria are met, or for weight management in adults with BMI 30 kg/m (or 27 kg/m with comorbidities) through specialist services
Since then mechanistic studies, animal models and human feeding studies have confirmed that ingestion of L-carnitine, choline and similar compounds raises urinary and breath levels of TMA and TMAO in many people
Nat Neurosci 2006;9(1):119-126
Esfandiari F, Favaedi R, Heidari-Khoei H, Chitsazian F, Yari S, Piryaei A, et al